Barretos Cancer Hospital also will immediately be able to exploit the benefits of Elekta treatment planning solutions. Monaco brings a fundamentally new approach to planning, featuring innovative biological cost functions with multi-criterial constrained optimization, a powerful leaf sequence optimizer and the Monte Carlo dose calculation algorithm.
XiO is a comprehensive 3D IMRT treatment planning platform that combines the latest tools and dose calculation algorithms.
Ad Statistics
Times Displayed: 50213
Times Visited: 1424 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
"Monaco and XiO are very sophisticated planning solutions that we predict will streamline plan development, while also ensuring the best possible clinical results for our patients," Dr. Gadia says.
Clarity 3D ultrasound benefits
Barretos will use its two Clarity systems - the first in Latin America - to provide image guidance for soft tissue targets. The center also intends to pursue clinical studies on the planning benefits of integrating 3D ultrasound with CT based planning. This work will help explore the local applicability of a relatively low-cost imaging modality that could be retrofitted on existing equipment in the region.
"Clarity will be another way to obtain fast, accurate soft tissue IGRT that we can integrate with any of our linear accelerators, with the added benefit of non-invasiveness," he says.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.
Website: www.elekta.com
.
Back to HCB News
